When it comes to brain stimulation, small differences in location can have a significant impact.
The brain is not organized into broad, isolated regions working independently. It functions through highly interconnected neural networks, many of which are separated by only millimeters but serve very different roles in mood regulation, cognition, emotional processing, and behavior.
This is why precision matters.
At Neurotherapeutix, computational brain mapping is used to identify the specific neural circuits underlying each patient’s symptoms before treatment begins.
Rather than relying on generalized anatomical assumptions, clinicians use fMRI-based connectivity analysis and neuronavigation to guide stimulation with millimeter-level accuracy.
This precision-driven approach is one of the defining differences between standard TMS protocols and personalized fMRI-guided treatment.
The problem with “close enough” in brain stimulation
In many areas of medicine, “close enough” may still produce acceptable results. In brain stimulation, however, even slight differences in targeting can affect which neural networks are being stimulated.
Two treatment targets may appear anatomically similar while functioning very differently within the brain’s connectivity system. Stimulating one network may support emotional regulation and symptom improvement, while stimulating a nearby but different circuit may produce less effective or inconsistent results.
This is especially important in mental health conditions, where symptoms are often linked to disruptions in network communication rather than visible structural abnormalities.
The challenge is not simply reaching the brain — it is reaching the right network with enough precision and consistency to influence how that network functions over time.
What standard TMS gets right — and what it can’t account for
Standard transcranial magnetic stimulation (TMS) has helped expand access to non-invasive brain stimulation and remains an important treatment option for many patients.
According to the National Institute of Mental Health, TMS is an established brain stimulation therapy used for certain mental health conditions.
However, traditional protocols often rely on generalized anatomical targeting methods based on average brain positioning rather than individual connectivity patterns.
This approach assumes that the same anatomical location will produce similar outcomes across patients, even though no two brains function exactly alike.
At Neurotherapeutix, the goal is to move beyond generalized positioning with fMRI-guided TMS therapy rather than standard TMS and to evaluate how each patient’s neural networks communicate individually.
This distinction is critical because symptoms such as depression, anxiety, post-traumatic stress disorder (PTSD), and cognitive dysfunction are often tied to network-level disruptions rather than a single isolated brain region.
What precision brain mapping actually measures
Precision brain mapping focuses on functional connectivity — how different regions of the brain communicate and coordinate with one another.
At Neurotherapeutix, this process is guided through rsfMRI, or resting-state functional MRI, which evaluates brain network activity while the patient is at rest.
Unlike structural imaging alone, rsfMRI helps clinicians understand how neural systems interact in real time.
From blood oxygen signals to a connectivity map
rsfMRI measures subtle fluctuations in blood oxygen levels, known as BOLD signals, which reflect neural activity across different brain regions.
By analyzing these signals computationally, clinicians can identify:
- Networks that may be overactive or underactive
- Patterns of disrupted communication
- Connectivity associated with mood, cognition, or emotional regulation
Research has shown that connectivity-based targeting may improve antidepressant response in TMS by aligning stimulation with symptom-related neural networks.
This information becomes the foundation for personalized targeting.
Patients interested in imaging comparisons can also explore rsfMRI vs. SPECT imaging to better understand how different technologies evaluate brain function.
How millimeter resolution translates to a treatment target
MRI technology offers extremely high spatial resolution, allowing clinicians to evaluate brain structures and connectivity patterns with remarkable detail.
In practical terms, this means clinicians can identify highly specific treatment targets rather than relying on generalized coordinates.
Millimeter-level accuracy matters because nearby brain regions may belong to entirely different neural networks. Precision targeting helps ensure stimulation is directed toward the circuits most closely associated with the patient’s symptoms.
How Neurotherapeutix achieves millimeter accuracy
At Neurotherapeutix, precision extends beyond the initial scan and continues throughout treatment.
Once imaging and computational analysis identify the appropriate target, clinicians use fMRI-guided TMS therapy protocols combined with neuronavigation technology to maintain highly accurate positioning during every session.
This approach helps ensure that treatment remains aligned with the intended neural circuits across the full course of therapy.
The role of neuronavigation in every TMS session
Neuronavigation acts as a real-time guidance system during treatment.
Using imaging data and spatial tracking, clinicians can precisely position the TMS coil relative to the patient’s individualized treatment target. This allows for consistent targeting session after session.
Without neuronavigation, even small shifts in positioning could alter which brain networks receive stimulation.
At Neurotherapeutix, maintaining precision across sessions is considered essential because consistent targeting supports more reliable network modulation over time.
Why consistent targeting across sessions matters
TMS therapy is not a one-time intervention. It works through repeated stimulation over multiple sessions as the brain gradually adapts and strengthens new connectivity patterns.
This process is tied to neuroplasticity — the brain’s ability to reorganize and form new neural pathways.
If targeting varies significantly between sessions, stimulation may not consistently engage the same neural circuits. Precision and consistency help reinforce the intended network changes throughout treatment.
This is one reason why individualized targeting and neuronavigation can play such an important role in treatment planning and long-term outcomes.
You can learn more about how it works now.
What this means for your treatment outcomes
For patients, precision-guided care means treatment is designed around how their brains function —not around generalized averages.
This may help:
- Improve targeting accuracy
- Better align stimulation with symptom-related networks
- Support more consistent modulation across sessions
- Create more meaningful and durable changes in connectivity
At Neurotherapeutix, precision is viewed as a clinical necessity rather than an added feature.
The goal is not simply to stimulate the brain, but to stimulate the right networks with the level of accuracy needed to support individualized treatment outcomes.
Precision starts here
At Neurotherapeutix, advanced imaging, computational analysis, and neuronavigation are integrated to create a more precise and personalized approach to brain stimulation.
By combining fMRI-guided targeting with millimeter-level accuracy, clinicians can tailor treatment to the neural circuits most closely associated with each patient’s symptoms.
If you are interested in learning more about precision-guided care, you can request a consultation to speak with the team.
Frequently asked questions
How precise is Neurotherapeutix’s brain mapping compared to standard TMS?
Standard TMS often relies on generalized anatomical landmarks, while Neurotherapeutix uses fMRI-guided computational brain mapping and neuronavigation to identify and target individualized neural circuits with millimeter-level accuracy.
What is neuronavigation, and how is it used during TMS sessions?
Neuronavigation is an advanced guidance system that uses imaging data and spatial tracking to allow clinicians to visualize the brain while the patient is comfortably seated in the treatment chair. This technology enables us to precisely position the coil over the exact brain regions identified during computational brain mapping. By continuously guiding placement and monitoring movement in real time, the system ensures highly accurate, consistent targeting across every session.
Does millimeter precision actually improve treatment outcomes?
Yes. Research suggests that connectivity-based targeting significantly improves treatment response by doing more than just providing millimeter precision. It allows us to detect the exact, specific regions of the brain that are malfunctioning for each patient. By aligning stimulation directly with these symptom-related neural networks, this precision targeting ensures a highly personalized approach and maintains consistent precision throughout the entire treatment course.
Does insurance cover fMRI-guided computational brain mapping?
Neurotherapeutix is a private-pay practice. We do not submit claims, contact insurance companies, or handle reimbursement matters on behalf of patients. Instead, we provide visit summaries, superbills, medical records, and billing documentation so patients can independently pursue out-of-network reimbursement if they choose.
Who is a good candidate for computational brain mapping?
Individuals seeking a highly personalized approach to TMS therapy are excellent candidates, particularly those with treatment-resistant conditions or prior experience with standard TMS.
Furthermore, patients with any symptoms are good candidates, as our computational brain mapping technology provides a thorough analysis of whole-brain activity and connectivity. This comprehensive evaluation supports specific diagnoses, uncovers the neurological root of your symptoms, and creates a personalized care plan by identifying the exact brain regions to target for treatment.
